Flossbach Von Storch AG Buys 1,890 Shares of Colgate-Palmolive (NYSE:CL)

Flossbach Von Storch AG increased its stake in Colgate-Palmolive (NYSE:CL) by 0.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 330,585 shares of the company’s stock after purchasing an additional 1,890 shares during the period. Flossbach Von Storch AG’s holdings in Colgate-Palmolive were worth $26,351,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. &PARTNERS lifted its stake in shares of Colgate-Palmolive by 0.7% during the 4th quarter. &PARTNERS now owns 17,643 shares of the company’s stock worth $1,406,000 after purchasing an additional 129 shares during the last quarter. West Branch Capital LLC lifted its stake in shares of Colgate-Palmolive by 24.0% during the 4th quarter. West Branch Capital LLC now owns 682 shares of the company’s stock worth $54,000 after purchasing an additional 132 shares during the last quarter. Gladstone Institutional Advisory LLC lifted its stake in shares of Colgate-Palmolive by 2.1% during the 1st quarter. Gladstone Institutional Advisory LLC now owns 6,329 shares of the company’s stock worth $476,000 after purchasing an additional 133 shares during the last quarter. First Foundation Advisors lifted its stake in shares of Colgate-Palmolive by 2.7% during the 3rd quarter. First Foundation Advisors now owns 5,226 shares of the company’s stock worth $372,000 after purchasing an additional 136 shares during the last quarter. Finally, Waldron Private Wealth LLC lifted its stake in shares of Colgate-Palmolive by 2.7% during the 3rd quarter. Waldron Private Wealth LLC now owns 5,361 shares of the company’s stock worth $381,000 after purchasing an additional 140 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Colgate-Palmolive news, Director C Martin Harris sold 2,760 shares of the stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $84.50, for a total transaction of $233,220.00. Following the transaction, the director now owns 19,272 shares in the company, valued at $1,628,484. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, insider Jennifer Daniels sold 3,538 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $84.67, for a total value of $299,562.46. Following the transaction, the insider now owns 59,698 shares in the company, valued at $5,054,629.66. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director C Martin Harris sold 2,760 shares of the firm’s stock in a transaction that occurred on Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total value of $233,220.00. Following the completion of the transaction, the director now owns 19,272 shares in the company, valued at approximately $1,628,484. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 232,371 shares of company stock worth $19,505,099. 0.37% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

CL has been the subject of a number of analyst reports. Stifel Nicolaus upped their price objective on Colgate-Palmolive from $89.00 to $94.00 and gave the stock a “buy” rating in a research note on Wednesday, April 10th. UBS Group increased their price target on Colgate-Palmolive from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Monday, January 29th. Wells Fargo & Company increased their price target on Colgate-Palmolive from $80.00 to $88.00 and gave the company an “equal weight” rating in a research note on Monday, January 29th. Evercore ISI increased their price target on Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a research note on Monday, April 8th. Finally, The Goldman Sachs Group began coverage on Colgate-Palmolive in a research note on Friday, March 1st. They issued a “buy” rating and a $93.00 price target for the company. Three investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $89.50.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock traded up $0.60 during midday trading on Wednesday, hitting $86.77. 3,885,531 shares of the company were exchanged, compared to its average volume of 4,547,918. The firm has a market capitalization of $71.32 billion, a PE ratio of 31.21, a price-to-earnings-growth ratio of 3.28 and a beta of 0.42. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $90.37. The business has a fifty day simple moving average of $86.97 and a two-hundred day simple moving average of $80.63. The company has a debt-to-equity ratio of 8.59, a quick ratio of 0.71 and a current ratio of 1.11.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 26th. The company reported $0.87 EPS for the quarter, topping the consensus estimate of $0.85 by $0.02. The firm had revenue of $4.95 billion for the quarter, compared to analyst estimates of $4.89 billion. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. Colgate-Palmolive’s revenue for the quarter was up 6.9% compared to the same quarter last year. During the same period last year, the company earned $0.77 earnings per share. On average, sell-side analysts forecast that Colgate-Palmolive will post 3.49 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be given a dividend of $0.50 per share. The ex-dividend date is Friday, April 19th. This represents a $2.00 dividend on an annualized basis and a yield of 2.30%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio is currently 69.06%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.